Editorial

A Role for Extracorporeal Treatment in Severe Influenza?

Authors: Nausherwan K. Burki, MD, PhD

Abstract

Influenza occurs worldwide as a seasonal infection. The influenza virus is enclosed in an envelope containing the glycoproteins hemagglutinin and neuraminidase. It has been known for many decades that the virus mutates to form new subtypes and strains, which are named according to the antigenic types of hemagglutinin and neuraminidase, thus influenza A (H3N2), etc. A gradual change (antigenic drift) in the antigenic properties produces new strains; influenza vaccines are reformulated every year to take this antigenic drift into account. A more abrupt change (antigenic shift) may produce a new subtype. Usually, these mutations do not produce any significant change in virulence. Occasionally the mutated virus may be devastating in terms of morbidity and mortality, as was seen in the great flu pandemic of 1918–1919, caused by an influenza A (H1N1) virus, when nearly 20 million people are believed to have died worldwide. A second pandemic of influenza A (H2N2) occurred in 1957–1958, accounting for nearly 70,000 deaths in the US, followed by a third pandemic of influenza A (H3N2) in 1968.1

This content is limited to qualifying members.

Existing members, please login first.

If you have an existing account please login now to access this article or view your purchase options.

Purchase only this article ($15)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. Smith GJ, Bahl J, Vijaykrishna D, et al. Dating the emergence of pandemic influenza viruses. Proc Natl Acad Sci U S A 2009;106:11709–11712.
 
2. Chowell G, Bertozzi SM, Colchero MA, et al. Severe respiratory disease concurrent with the circulation of H1N1 influenza. N Engl J Med 2009;361:674–679.
 
3. Centers for Disease Control and Prevention (CDC). Swine influenza A(H1N1) infection in 2 children – Southern California March—April 2009. MMWR Morb Mortal Wkly Rep 2009;58:400–402.
 
4. Wenzel RP. What we learned from H1N1's first year. New York Times, April 13, 2010.
 
5. Editorial: a year after H1N1 outbreak, a look at what could be done better. Wall Street Journal, April 12, 2010.
 
6. Homsi S, Milojkovic N, Homsi Y. Clinical pathological characteristics of acute respiratory distress syndrome resulting from influenza A (H1N1) virus and their impact on management. South Med J 2010;103:787–793.
 
7. Centers for Disease Control and Prevention (CDC). Intensive care patients with severe novel influenza A (H1N1) virus infection—Michigan, June 2009. MMWR Morb Mortal Wkly Rep 2009;58:749–752.
 
8. Davies A, Jones D, Bailey M, et al. Extracorporeal membrane oxygenation for 2009 influenza A(H1N1) acute respiratory distress syndrome. JAMA 2009;302:1888–1895.
 
9. Buckley E, Sidebotham D, McGeorge A, et al. Extracorporeal membrane oxygenation for cardiorespiratory failure in four patients with pandemic H1N1 2009 influenza virus and secondary bacterial infection. Br J Anaesth 2010;104:326–329.
 
10. Freed DH, Henzler D, White CW, et al; Canadian Critical Care Trials Group. Extracorporeal lung support for patients who had severe respiratory failure secondary to influenza A (H1N1) 2009 infection in Canada. Can J Anaesth 2010;57:240–247.
 
11. Miller E, Hoschler K, Hardelid P, et al. Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study. Lancet 2010;375:1100–1108.
 
12. Hui DS, Lee N, Chan PK. Clinical management of pandemic 2009 influenza A(H1N1) infection. Chest 2010;137:916–925.
 
13. Centers for Disease Control and Prevention. Updated interim recommendations for obstetric health care providers related to use of antiviral medications in the treatment and prevention of influenza for the 2009–2010 season. Available at: http://www.cdc.gov/h1n1flu/pregnancy/antiviral_messages.htm. Accessed April 16, 2010.
 
14. Louie JK, Acosta M, Jamieson DJ, et al; California Pandemic (H1N1) Working Group. Severe 2009 H1N1 influenza in pregnant and postpartum women in California. N Engl J Med 2010;362:27–35.